TUO0 Stock Overview
Terumo Corporation engages in the manufacture and sale of medical products and equipment in Japan, Europe, China, the United States, Asia, and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 2/6 |
| Past Performance | 5/6 |
| Financial Health | 6/6 |
| Dividends | 4/6 |
Terumo Corporation Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | JP¥15.20 |
| 52 Week High | JP¥32.20 |
| 52 Week Low | JP¥15.00 |
| Beta | 0.50 |
| 1 Month Change | -48.99% |
| 3 Month Change | n/a |
| 1 Year Change | n/a |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -48.99% |
Recent News & Updates
No updates
Recent updates
No updates
Shareholder Returns
| TUO0 | DE Medical Equipment | DE Market | |
|---|---|---|---|
| 7D | 0.7% | -1.9% | -0.5% |
| 1Y | n/a | -12.2% | 2.5% |
Return vs Industry: Insufficient data to determine how TUO0 performed against the German Medical Equipment industry.
Return vs Market: Insufficient data to determine how TUO0 performed against the German Market.
Price Volatility
| TUO0 volatility | |
|---|---|
| TUO0 Average Weekly Movement | n/a |
| Medical Equipment Industry Average Movement | 4.7% |
| Market Average Movement | 4.9% |
| 10% most volatile stocks in DE Market | 10.3% |
| 10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: TUO0's share price has been volatile over the past 3 months.
Volatility Over Time: Insufficient data to determine TUO0's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1921 | 30,207 | Hikaru Samejima | www.terumo.com |
Terumo Corporation engages in the manufacture and sale of medical products and equipment in Japan, Europe, China, the United States, Asia, and internationally. The company operates through three segments: Cardiac and Vascular Company, Medical Care Solutions Company, and Blood and Cell Technologies Company. The Cardiac and Vascular Company segment offers angiographic guidewires, angiographic catheters, introducer sheaths, vascular closure devices, PTCA balloon catheters, coronary stents, self-expanding peripheral stents, intravascular ultrasound systems, imaging catheters, and others; coils, stents, and intrasaccular devices for treating cerebral aneurysm; embolization systems, aspiration catheters, and clot retrievers for treating ischemic stroke and others; oxygenators, cardio-pulmonary bypass systems, and others; and artificial vascular and stent grafts.
Terumo Corporation Fundamentals Summary
| TUO0 fundamental statistics | |
|---|---|
| Market cap | €24.04b |
| Earnings (TTM) | €602.28m |
| Revenue (TTM) | €5.38b |
39.9x
P/E Ratio4.5x
P/S RatioIs TUO0 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| TUO0 income statement (TTM) | |
|---|---|
| Revenue | JP¥885.17b |
| Cost of Revenue | JP¥431.30b |
| Gross Profit | JP¥453.86b |
| Other Expenses | JP¥354.82b |
| Earnings | JP¥99.04b |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
May 14, 2024
| Earnings per share (EPS) | 66.71 |
| Gross Margin | 51.27% |
| Net Profit Margin | 11.19% |
| Debt/Equity Ratio | 18.6% |
How did TUO0 perform over the long term?
See historical performance and comparison